Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Boswellic acid, a major active component of the resin from Boswellia species (frankincense), has been investigated for its anti-inflammatory properties. There is emerging scientific evidence suggesting that boswellic acids may be beneficial in the management of gingivitis, primarily due to their ability to inhibit pro-inflammatory enzymes (such as 5-lipoxygenase), reduce leukocyte infiltration, and modulate cytokine production in oral tissues. Several small-scale clinical studies and randomized controlled trials have evaluated Boswellia extracts (often standardized to boswellic acid content) in oral health applications. For example, some studies have demonstrated that mouthwashes or gels containing Boswellia extracts can reduce plaque and gingival inflammation when used as adjuncts to mechanical oral hygiene.

However, most available studies are limited by small sample sizes, short durations, and methodological weaknesses. Systematic reviews and meta-analyses acknowledge the potential but emphasize the need for larger, high-quality clinical trials to confirm efficacy and safety. While Boswellia has a long tradition in Ayurvedic and herbal medicine for inflammatory conditions, its specific application for gingivitis is primarily supported by recent scientific research rather than traditional use. Thus, while boswellic acid shows promise and has some scientific backing for gingivitis, the overall quality and quantity of evidence are moderate, warranting a cautious evidence rating of 2/5.

More about Boswellic Acid
More about Gingivitis

Other ingredients used for Gingivitis

Other health conditions supported by Boswellic Acid

Products containing Boswellic Acid